Motixafortide
Motixafortide Uses, Dosage, Side Effects, Food Interaction and all others data.
Motixafortide is under investigation in clinical trial NCT01838395 (Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients).
Trade Name | Motixafortide |
Generic | Motixafortide |
Motixafortide Other Names | Motixafortide |
Type | |
Formula | C97H144FN33O19S2 |
Weight | Average: 2159.55 Monoisotopic: 2158.07417006 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Motixafortide